Cargando…

Treatment of Chronic HCV Infection in Special Populations

The mainstay of treatment of chronic hepatitis C is pegylated interferon combined with ribavirin and more than 50% of naïve patients will have viral cure with either 6 months (genotypes 2 and 3) or 12 months (genotypes 1,4, and 6) with the initial treatment. However, populations have been defined th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hoefs, John, Aulakh, Vikramjit S.
Formato:	Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2006
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1415846/ https://www.ncbi.nlm.nih.gov/pubmed/16614746

Ejemplares similares

Special Issue “Chronic HCV Infection: Clinical Advances and Eradication Perspectives”
por: Liberto, Maria Carla, et al.
Publicado: (2022)

HCV-Specific T Cell Responses During and After Chronic HCV Infection
por: Luxenburger, Hendrik, et al.
Publicado: (2018)

Key Elements on the Pathway to HCV Elimination: Lessons Learned From the AASLD HCV Special Interest Group 2020
por: Feld, Jordan J., et al.
Publicado: (2021)

Chronic HCV infection: epidemiological and clinical relevance
por: Zaltron, S, et al.
Publicado: (2012)

Reversal of T Cell Exhaustion in Chronic HCV Infection
por: Osuch, Sylwia, et al.
Publicado: (2020)

Pathogenesis of Thrombocytopenia in Chronic HCV Infection: A Review
por: Rawi, Sarah, et al.
Publicado: (2020)

Lipid Metabolism and HCV Infection
por: Targett-Adams, Paul, et al.
Publicado: (2010)

Hepatocellular Carcinoma Mechanisms Associated with Chronic HCV Infection and the Impact of Direct-Acting Antiviral Treatment
por: Dash, Srikanta, et al.
Publicado: (2020)

LncRNAs in HCV Infection and HCV-Related Liver Disease
por: Unfried, Juan P., et al.
Publicado: (2020)

Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients with Chronic HCV Infection
por: Liu, Xiaoqing, et al.
Publicado: (2021)

Chronic HCV infection and neuropsychiatric dysfunction
por: Fortini, Ida, et al.
Publicado: (2019)

Restoration of HCV-Specific Immune Responses with Antiviral Therapy: A Case for DAA Treatment in Acute HCV Infection
por: Casey, Julia L., et al.
Publicado: (2019)

Antiviral resistance in HCV strains isolated from Romanian patients with limited treatment options for chronic HCV infection
por: Streinu-Cercel, Anca, et al.
Publicado: (2014)

Impact of chronic schistosomiasis and HBV/HCV co-infection on the liver: current perspectives
por: Omar, Hanan Hassan
Publicado: (2019)

Determination of HCV genotypes and viral loads in chronic HCV infected patients of Hazara Pakistan
por: Ali, Amjad, et al.
Publicado: (2011)

Characterization of chronic HCV infection-induced apoptosis
por: Zekri, Abdel-Rahman N, et al.
Publicado: (2011)

Metabolic features in chronic HCV infected patients
por: Rădulescu, Mihaela Andreea, et al.
Publicado: (2013)

Molecular surveillance of HCV mono-infection and HCV-HBV co-infection in symptomatic population at Hyderabad, Pakistan
por: Patoli, Bushra B, et al.
Publicado: (2018)

Regulation of gene expression by microRNA in HCV infection and HCV–mediated hepatocellular carcinoma
por: Gupta, Priyanka, et al.
Publicado: (2014)

The Undiagnosed Chronically-Infected HCV Population in France. Implications for Expanded Testing Recommendations in 2014
por: Brouard, Cécile, et al.
Publicado: (2015)

Management of HCV Infection and Liver Transplantation
por: Schiano, Thomas D., et al.
Publicado: (2006)

Interferon-λ in HCV Infection and Therapy
por: Pagliaccetti, Nicole E., et al.
Publicado: (2010)

The role of CCR5 in HCV infection
por: Coenen, Martin, et al.
Publicado: (2010)

Hepcidin and the iron enigma in HCV infection
por: Georgopoulou, Urania, et al.
Publicado: (2014)

Oncogenic Signaling Induced by HCV Infection
por: Virzì, Alessia, et al.
Publicado: (2018)

The Impact of Antiviral Therapy and the Influence of Metabolic Cofactors on the Outcome of Chronic HCV Infection
por: Persico, Marcello, et al.
Publicado: (2011)

A New Twist to a Chronic HCV Infection: Occult Hepatitis C
por: Attar, Bashar M., et al.
Publicado: (2015)

Interferon Response in Hepatitis C Virus (HCV) Infection: Lessons from Cell Culture Systems of HCV Infection
por: Sung, Pil Soo, et al.
Publicado: (2015)

Overview of HCV Life Cycle with a Special Focus on Current and Possible Future Antiviral Targets
por: Alazard-Dany, Nathalie, et al.
Publicado: (2019)

Impact of DAA Treatment on Cardiovascular Disease Risk in Chronic HCV Infection: An Update
por: Roguljic, Hrvoje, et al.
Publicado: (2021)

HCV treatment in children and young adults with HIV/HCV co-infection in Europe
por: Turkova, Anna, et al.
Publicado: (2015)

Treatment of hepatitis C in special populations
por: Suda, Goki, et al.
Publicado: (2018)

Current and Future Disease Progression of the Chronic HCV Population in the United States
por: Zalesak, Martin, et al.
Publicado: (2013)

Orbital Pseudotumor as an Extrahepatic Complication of Chronic HCV Infection
por: Huang, Owen, et al.
Publicado: (2018)

The role of HCV proteins on treatment outcomes
por: Kumthip, Kattareeya, et al.
Publicado: (2015)

Recent advances in managing chronic HCV infection: focus on therapy in patients with severe liver disease
por: Maan, Raoel, et al.
Publicado: (2016)

The Role of the Microbiota Gut–Liver Axis during HCV Chronic Infection: A Schematic Overview
por: Marascio, Nadia, et al.
Publicado: (2022)

Insights on the Russian HCV care cascade: minimal HCV treatment for HIV/HCV co-infected PWID in St. Petersburg
por: Tsui, Judith I., et al.
Publicado: (2016)

Pangenotypic and Genotype-Specific Antivirals in the Treatment of HCV Genotype 4 Infected Patients with HCV Monoinfection and HIV/HCV Coinfection
por: Zarębska-Michaluk, Dorota, et al.
Publicado: (2022)

HCV Infection and B-Cell Lymphomagenesis
por: Ito, Masahiko, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_993454341datruv47decil73tr